Lipoic acid in secondary progressive MS: A randomized controlled pilot trial

OBJECTIVE: To determine whether lipoic acid (LA), an endogenously produced antioxidant, slowed the whole-brain atrophy rate and was safe in secondary progressive MS (SPMS). METHODS: Patients with SPMS aged 40–70 years enrolled in a single center, 2-year, double-blind, randomized trial of daily oral...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neurol Neuroimmunol Neuroinflamm
Egile Nagusiak: Spain, Rebecca, Powers, Katherine, Murchison, Charles, Heriza, Elizabeth, Winges, Kimberly, Yadav, Vijayshree, Cameron, Michelle, Kim, Ed, Horak, Fay, Simon, Jack, Bourdette, Dennis
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lippincott Williams & Wilkins 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5489387/
https://ncbi.nlm.nih.gov/pubmed/28680916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000374
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak